Togo has received validation from the World Health Organization (WHO) for having eliminated human African trypanosomiasis or “sleeping sickness” as a public health problem, becoming the first country ...

Acoziborole could change that. The new drug works for both early and advanced stages of the most common form of sleeping ...

For use outside the EU, the regulator backed a single-dose oral approach that treats all stages and could spare patients ...

Thanks to efforts by MSF, the immediate future for those with sleeping sickness looks considerably brighter than the recent past, but the long-term prognosis isn't clear. The story of the reemergence ...

A single dose of oral acoziborole proved to be efficacious and safe for adults and adolescents with gambiense human African trypanosomiasis (HAT), also known as "sleeping sickness," suggesting its ...

In another step to combat deadly African sleeping sickness, the Bill & Melinda Gates Foundation has presented a $22.6 million grant to the University of North Carolina at Chapel Hill to fund a Phase ...

A single dose of oral acoziborole resulted in a greater than 95% cure or probable cure rate for human African trypanosomiasis (HAT), also known as sleeping sickness, according to results from a ...

Over four million people in northern Kenya are facing severe hunger as the worst drought in 40 years devastates the Horn of Africa - Copyright AFP Anatolii Stepanov ...